Scrip Asks…What Does 2024 Hold for Biopharma?

Jan 2024

James West, Managing Director in Lincoln’s Healthcare Group, recently discussed his expectations for the biopharma market in 2024 as part of Scrip’s series.

Summary

Contributor

Meet Professionals with Complementary Expertise in Mergers & Acquisitions

Related Perspectives in Mergers & Acquisitions

PETS International | Consolidation Meets Regulation in the Veterinary Clinics Market

Originally posted by PETS International on April 5, 2024. Animal health is becoming a big business in Europe and the U.S. Thus, regulators are turning a closer eye to mergers… Read More

“Leader to Leader” Series

The Leader to Leader video series turns up the dial on rich conversations with prominent leaders – from business owners and entrepreneurs to investors and CEOs – highlighting their stories… Read More

Room for Growth: Home Furnishings Industry Showing Areas of Opportunity

Few industries have experienced highs and lows as much as the home furnishings sector over the last three years. Driven by COVID-19 stay-at-home measures and remote work, the industry saw… Read More

Affärsvärlden | European Companies Performing Well

Originally posted by Affärsvärlden on March 14, 2024. European companies are outperforming their U.S. counterparts. Proprietary data provided by Lincoln’s Valuations & Opinions Group revealed that European medium-sized companies are… Read More